Discrepancies in the evaluation of the safety of the human papillomavirus vaccine
Despite being more than ten years since its introduction, global acceptance to the human papillomavirus (HPV) vaccine is still low. The immunogenetic background of the host, and HPV antigen recognition, are important in natural HPV infection, and shoul
Ed Rybicki’s insight:
Very interesting article – that actually points out some complications with OTHER vaccines, that I’d never heard of.
Discrepancies in the evaluation of the safety of the human papillomavirus vaccine
Source: Virology News
